Puma Biotech: Is It Time For This Kitty To Roar?
October 10, 2018 at 23:29 PM EDT
Puma is an oncology company with drug Nerlynx approved for HER2 positive adjuvant breast cancer. But the market has yet to appreciate the drug’s full potential.
